Rhythm Pharmaceuticals Stock Volatility
| RYTM Stock | USD 102.40 0.13 0.13% |
As of now, Rhythm Stock is very steady. Rhythm Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0254, which implies the firm had a 0.0254 % return per unit of risk over the last 3 months. We have found twenty-six technical indicators for Rhythm Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Rhythm Pharmaceuticals' Coefficient Of Variation of 3568.14, risk adjusted performance of 0.0298, and Semi Deviation of 2.81 to confirm if the risk estimate we provide is consistent with the expected return of 0.0836%.
Sharpe Ratio = 0.0254
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | RYTM | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Rhythm Pharmaceuticals is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rhythm Pharmaceuticals by adding it to a well-diversified portfolio.
Key indicators related to Rhythm Pharmaceuticals' volatility include:90 Days Market Risk | Chance Of Distress | 90 Days Economic Sensitivity |
Rhythm Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Rhythm daily returns, and it is calculated using variance and standard deviation. We also use Rhythm's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Rhythm Pharmaceuticals volatility.
ESG Sustainability
While most ESG disclosures are voluntary, Rhythm Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Rhythm Pharmaceuticals' managers and investors.Environmental | Governance | Social |
Using Rhythm Put Option to Manage Risk
Put options written on Rhythm Pharmaceuticals grant holders of the option the right to sell a specified amount of Rhythm Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Rhythm Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Rhythm Pharmaceuticals' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Rhythm Pharmaceuticals will be realized, the loss incurred will be offset by the profits made with the option trade.
Rhythm Pharmaceuticals' PUT expiring on 2026-04-17
Profit |
| Rhythm Pharmaceuticals Price At Expiration |
Current Rhythm Pharmaceuticals Insurance Chain
| Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Put | RYTM260417P00050000 | -0.093341 | 0.002099 | 3 | 2026-04-17 | 0.0 - 5.0 | 0.0 | View |
Put | RYTM260417P00055000 | -0.088716 | 0.002619 | 13 | 2026-04-17 | 0.0 - 3.3 | 0.0 | View |
Put | RYTM260417P00060000 | -0.11871 | 0.003118 | 6 | 2026-04-17 | 0.0 - 5.0 | 0.0 | View |
Put | RYTM260417P00065000 | -0.133632 | 0.0038 | 7 | 2026-04-17 | 0.0 - 5.0 | 0.0 | View |
Put | RYTM260417P00070000 | -0.150658 | 0.00465 | 2 | 2026-04-17 | 0.0 - 5.0 | 0.0 | View |
Put | RYTM260417P00075000 | -0.155503 | 0.006006 | 4 | 2026-04-17 | 0.0 - 3.9 | 0.0 | View |
Put | RYTM260417P00090000 | -0.261895 | 0.011818 | 41 | 2026-04-17 | 2.6 - 7.5 | 0.0 | View |
Put | RYTM260417P00095000 | -0.330051 | 0.013446 | 10 | 2026-04-17 | 4.9 - 8.7 | 0.0 | View |
Put | RYTM260417P00100000 | -0.403792 | 0.014797 | 18 | 2026-04-17 | 7.2 - 10.5 | 0.0 | View |
Put | RYTM260417P00105000 | -0.481645 | 0.015703 | 2 | 2026-04-17 | 9.5 - 13.0 | 0.0 | View |
Put | RYTM260417P00110000 | -0.556423 | 0.015547 | 1 | 2026-04-17 | 12.5 - 16.2 | 0.0 | View |
Rhythm Pharmaceuticals Stock Volatility Analysis
Volatility refers to the frequency at which Rhythm Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Rhythm Pharmaceuticals' price changes. Investors will then calculate the volatility of Rhythm Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Rhythm Pharmaceuticals' volatility:
Historical Volatility
This type of stock volatility measures Rhythm Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Rhythm Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Rhythm Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Rhythm Pharmaceuticals' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Rhythm Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Rhythm Pharmaceuticals Projected Return Density Against Market
Given the investment horizon of 90 days Rhythm Pharmaceuticals has a beta of 0.9961 indicating Rhythm Pharmaceuticals market returns are highly reactive to returns on the market. As the market goes up or down, Rhythm Pharmaceuticals is expected to follow.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Rhythm Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Rhythm Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Rhythm stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Predicted Return Density |
| Returns |
What Drives a Rhythm Pharmaceuticals Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract investor attention to the company. This positive attention may impact the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Rhythm Pharmaceuticals Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Rhythm Pharmaceuticals is 3934.46. The daily returns are distributed with a variance of 10.81 and standard deviation of 3.29. The mean deviation of Rhythm Pharmaceuticals is currently at 2.46. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.79
α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 1.00 | |
σ | Overall volatility | 3.29 | |
Ir | Information ratio | 0.01 |
Rhythm Pharmaceuticals Stock Return Volatility
Rhythm Pharmaceuticals historical daily return volatility represents how much of Rhythm Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 3.2879% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7573% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Rhythm Stock performing well and Rhythm Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rhythm Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RVMD | 2.35 | 0.78 | 0.21 | (33.16) | 2.97 | 4.56 | 45.50 | |||
| AKRO | 1.14 | 0.30 | 0.24 | 0.56 | 0.63 | 3.29 | 16.73 | |||
| RNA | 0.15 | 0.03 | (0.04) | 0.45 | 0.00 | 0.35 | 1.42 | |||
| PTGX | 1.60 | (0.07) | 0.00 | (0.07) | 0.00 | 3.18 | 8.01 | |||
| STOK | 2.99 | 0.36 | 0.10 | 0.51 | 3.07 | 7.31 | 22.52 | |||
| QURE | 3.67 | (0.45) | 0.00 | (0.72) | 0.00 | 8.71 | 20.91 | |||
| RCKT | 2.82 | 0.02 | 0.01 | 0.06 | 3.26 | 8.04 | 19.80 | |||
| SLDB | 3.37 | 0.67 | 0.19 | 1.01 | 3.09 | 11.36 | 21.71 | |||
| MGTX | 2.56 | (0.27) | 0.00 | (0.12) | 0.00 | 5.08 | 16.37 | |||
| NUVL | 2.09 | 0.12 | 0.03 | 1.20 | 2.52 | 3.45 | 17.72 |
About Rhythm Pharmaceuticals Volatility
Volatility is a rate at which the price of Rhythm Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Rhythm Pharmaceuticals may increase or decrease. In other words, similar to Rhythm's beta indicator, it measures the risk of Rhythm Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Rhythm Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 2.4 B | 2.5 B |
Rhythm Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Rhythm Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Rhythm Pharmaceuticals' price varies over time.
3 ways to utilize Rhythm Pharmaceuticals' volatility to invest better
Higher Rhythm Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Rhythm Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Rhythm Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Rhythm Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Rhythm Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Rhythm Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Rhythm Pharmaceuticals Investment Opportunity
Rhythm Pharmaceuticals has a volatility of 3.29 and is 4.33 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Rhythm Pharmaceuticals is lower than 29 percent of all global equities and portfolios over the last 90 days. You can use Rhythm Pharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a normal downward trend and little activity. Check odds of Rhythm Pharmaceuticals to be traded at $101.38 in 90 days.Significant diversification
The correlation between Rhythm Pharmaceuticals and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rhythm Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Rhythm Pharmaceuticals Additional Risk Indicators
The analysis of Rhythm Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Rhythm Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Rhythm Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0298 | |||
| Market Risk Adjusted Performance | 0.0898 | |||
| Mean Deviation | 2.42 | |||
| Semi Deviation | 2.81 | |||
| Downside Deviation | 2.87 | |||
| Coefficient Of Variation | 3568.14 | |||
| Standard Deviation | 3.19 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Rhythm Pharmaceuticals Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Rhythm Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Rhythm Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Rhythm Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Rhythm Pharmaceuticals.
When determining whether Rhythm Pharmaceuticals is a strong investment it is important to analyze Rhythm Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rhythm Pharmaceuticals' future performance. For an informed investment choice regarding Rhythm Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Biotechnology sector continue expanding? Could Rhythm diversify its offerings? Factors like these will boost the valuation of Rhythm Pharmaceuticals. Anticipated expansion of Rhythm directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Rhythm Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.10) | Revenue Per Share | Quarterly Revenue Growth 0.543 | Return On Assets | Return On Equity |
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Rhythm Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rhythm Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Rhythm Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.